Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cary O Harding

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Biologics : Targets & Therapy|August 18, 2010
New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochlorideCary O Harding
Human Gene Therapy|December 17, 2013
Seeking a cure for the royal painCary O Harding
Molecular Frontiers Journal|June 12, 2020
Prospects for Cell-Directed Curative Therapy of Phenylketonuria (PKU)Cary O Harding
Lancet (London, England)|October 5, 2024
Sepiapterin: a potential new therapy for phenylketonuriaCary O Harding
Free Radical Biology & Medicine|May 22, 2003
L-2-oxothiazolidine-4-carboxylate supplementation in murine gamma-GT deficiencyPatrice Held, Cary O Harding
HGG Advances|June 7, 2024
Letter to the editorCary O Harding, Michael Martinez
Journal of Inherited Metabolic Disease|November 19, 2010
Advances and challenges in phenylketonuriaCary O Harding, Nenad Blau
Journal of Inherited Metabolic Disease|May 25, 2010
Therapeutic liver repopulation for phenylketonuriaCary O Harding, K M Gibson
Molecular Genetics and Metabolism|January 20, 2004
State-of-the-art 2003 on PKU gene therapyZhaobing Ding, Cary O Harding, Beat Thöny
Topics in Clinical Nutrition|July 1, 2010
EFFECT OF FEEDING, EXERCISE AND GENOTYPE ON PLASMA 3-HYDROXYACYLCARNITINES IN CHILDREN WITH LCHAD DEFICIENCYMelanie B Gillingham, Dietrich Matern, Cary O Harding
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Biologics : Targets & Therapy|August 18, 2010
New era in treatment for phenylketonuria: Pharmacologic therapy with sapropterin dihydrochlorideCary O Harding
Human Gene Therapy|December 17, 2013
Seeking a cure for the royal painCary O Harding
Molecular Frontiers Journal|June 12, 2020
Prospects for Cell-Directed Curative Therapy of Phenylketonuria (PKU)Cary O Harding
Lancet (London, England)|October 5, 2024
Sepiapterin: a potential new therapy for phenylketonuriaCary O Harding
Free Radical Biology & Medicine|May 22, 2003
L-2-oxothiazolidine-4-carboxylate supplementation in murine gamma-GT deficiencyPatrice Held, Cary O Harding
HGG Advances|June 7, 2024
Letter to the editorCary O Harding, Michael Martinez
Journal of Inherited Metabolic Disease|November 19, 2010
Advances and challenges in phenylketonuriaCary O Harding, Nenad Blau
Journal of Inherited Metabolic Disease|May 25, 2010
Therapeutic liver repopulation for phenylketonuriaCary O Harding, K M Gibson
Molecular Genetics and Metabolism|January 20, 2004
State-of-the-art 2003 on PKU gene therapyZhaobing Ding, Cary O Harding, Beat Thöny
Topics in Clinical Nutrition|July 1, 2010
EFFECT OF FEEDING, EXERCISE AND GENOTYPE ON PLASMA 3-HYDROXYACYLCARNITINES IN CHILDREN WITH LCHAD DEFICIENCYMelanie B Gillingham, Dietrich Matern, Cary O Harding
Pageof 12